PH20483A - Novel((bis(aryl)methylene)-1-piperidinyl)-alkyl-pyrimidinones pharmaceutical compositions containing same and method of use thereof - Google Patents
Novel((bis(aryl)methylene)-1-piperidinyl)-alkyl-pyrimidinones pharmaceutical compositions containing same and method of use thereofInfo
- Publication number
- PH20483A PH20483A PH29745A PH29745A PH20483A PH 20483 A PH20483 A PH 20483A PH 29745 A PH29745 A PH 29745A PH 29745 A PH29745 A PH 29745A PH 20483 A PH20483 A PH 20483A
- Authority
- PH
- Philippines
- Prior art keywords
- pyrimidinones
- piperidinyl
- methylene
- aryl
- bis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
- C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/46—Oxygen atoms
- C07D213/50—Ketonic radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43807982A | 1982-11-01 | 1982-11-01 | |
| US06/517,612 US4485107A (en) | 1982-11-01 | 1983-07-27 | [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH20483A true PH20483A (en) | 1987-01-16 |
Family
ID=27031541
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH29745A PH20483A (en) | 1982-11-01 | 1983-10-21 | Novel((bis(aryl)methylene)-1-piperidinyl)-alkyl-pyrimidinones pharmaceutical compositions containing same and method of use thereof |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US4485107A (pt) |
| EP (1) | EP0110435B1 (pt) |
| KR (1) | KR870000825B1 (pt) |
| AU (1) | AU559176B2 (pt) |
| BG (2) | BG51158A3 (pt) |
| CA (1) | CA1211438A (pt) |
| CS (1) | CS238396B2 (pt) |
| CY (1) | CY1607A (pt) |
| DE (1) | DE3378825D1 (pt) |
| DK (1) | DK168919B1 (pt) |
| ES (1) | ES8601965A1 (pt) |
| FI (1) | FI77868C (pt) |
| GR (1) | GR81277B (pt) |
| HK (1) | HK52691A (pt) |
| IE (1) | IE56180B1 (pt) |
| IL (1) | IL70094A0 (pt) |
| IN (1) | IN159576B (pt) |
| MA (1) | MA19941A1 (pt) |
| NO (1) | NO166133C (pt) |
| NZ (1) | NZ205993A (pt) |
| PH (1) | PH20483A (pt) |
| PT (1) | PT77493B (pt) |
| RO (1) | RO86698B (pt) |
| SG (1) | SG46791G (pt) |
| SU (1) | SU1313349A3 (pt) |
| ZW (1) | ZW23283A1 (pt) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4529727A (en) * | 1982-04-21 | 1985-07-16 | Janssen Pharmaceutical, N.V. | Pyrimido[2,1-b][1,3]-thiazines |
| US4581171A (en) * | 1983-07-27 | 1986-04-08 | Janssen Pharmaceutica, N.V. | [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones useful for treating psychotropic disorders |
| US4533665A (en) * | 1983-07-27 | 1985-08-06 | Janssen Pharmaceutica | [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones |
| US4888426A (en) * | 1983-11-30 | 1989-12-19 | Janssen Pharmaceutica N.V. | 1-(5-methyl-furan-2-ylmethyl)-N-(4-piperidinyl)imidazo [4,5-6]pyridine-2-amine |
| US4695569A (en) * | 1983-11-30 | 1987-09-22 | Janssen Pharmaceutica N.V. | Bicyclic heterocyclyl containing N-(bicyclic heterocyclyl)-4-piperidinamines |
| US4804663A (en) * | 1985-03-27 | 1989-02-14 | Janssen Pharmaceutica N.V. | 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles |
| US4874766A (en) * | 1986-09-22 | 1989-10-17 | Janssen Pharmaceutica N.V. | Method of promoting wound-healing |
| US4921854A (en) * | 1986-12-30 | 1990-05-01 | Egis Gyogyszergyar | Condensed thiazolopyrimidine, pyrimido-thiazine or thiazepine pyrimidine compounds |
| DE3738844A1 (de) * | 1987-11-16 | 1989-05-24 | Merck Patent Gmbh | Analgetikum |
| IL90858A (en) * | 1988-07-07 | 1994-08-26 | Rhone Poulenc Sante | History (Aza) Naftalensultam, their preparation and preparations containing them |
| IL90879A0 (en) * | 1988-09-02 | 1990-02-09 | Janssen Pharmaceutica Nv | 3-piperidinyl-indazole derivatives,their preparation and antihypertensive compositions containing them |
| US5158952A (en) * | 1988-11-07 | 1992-10-27 | Janssen Pharmaceutica N.V. | 3-[2-[4-(6-fluoro-1,2-benzisoxozol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9 tetrahydro-9-hydroxy-2-methyl-4H-pyrido [1,2-a]pyrimidin-4-one, compositions and method of use |
| US5140029A (en) * | 1989-01-09 | 1992-08-18 | Janssen Pharmaceutica N.V. | 2-aminopyrimidinone derivatives |
| GB8900382D0 (en) * | 1989-01-09 | 1989-03-08 | Janssen Pharmaceutica Nv | 2-aminopyrimidinone derivatives |
| US5256659A (en) * | 1989-01-09 | 1993-10-26 | Janssen Pharmaceutica N.V. | 2-aminopyrimidinone derivatives |
| FR2643373B1 (fr) * | 1989-01-10 | 1993-12-31 | Adir Cie | Nouveaux derives des bisarylalcenes, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent |
| GB9008850D0 (en) * | 1990-04-19 | 1990-06-13 | Janssen Pharmaceutica Nv | Novel 2,9-disubstituted-4h-pyridol(1,2-a)pyrimidin-4-ones |
| ES2050069B1 (es) * | 1992-07-10 | 1994-12-16 | Vita Invest Sa | Procedimiento para la obtencion de 3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-il)piperidino)etil)-2-metil-6,7,8,9-tetrahidro-4h-pirido(1,2-a) pirimidin-4-ona. |
| DK0729357T3 (da) | 1993-11-19 | 2005-06-06 | Janssen Pharmaceutica Nv | Mikroindkapslede 1,2-benzazoler |
| IL122072A (en) * | 1996-11-14 | 2001-03-19 | Akzo Nobel Nv | Piperidine derivatives their preparation and pharmaceutical compositions containing them |
| UA72189C2 (uk) | 1997-11-17 | 2005-02-15 | Янссен Фармацевтика Н.В. | Фармацевтична композиція, що містить водну суспензію субмікронних ефірів 9-гідроксирисперидон жирних кислот |
| UA75051C2 (en) | 1999-09-03 | 2006-03-15 | Syngenta Participations Ag | Tetrahydropiridines as pesticides, a composition, a method for the preparation thereof and a method of controlling pests |
| TW200400005A (en) * | 2002-02-11 | 2004-01-01 | Syngenta Participations Ag | Derivatives of (1-benzyl-piperidine-4-yl)-diphenyl-methanol |
| KR20040034996A (ko) * | 2002-10-18 | 2004-04-29 | 한미약품 주식회사 | 리스페리돈의 개선된 제조방법 |
| AU2003296373A1 (en) * | 2002-12-18 | 2004-07-29 | Bayer Cropscience Ag | N-(substituted arylmethyl)-4-(disubstituted methyl)piperidines and piperazines |
| EP1615924A1 (en) * | 2003-04-22 | 2006-01-18 | Synthon B.V. | Water soluble salts of risperidone |
| CA2681267C (en) | 2007-04-13 | 2013-11-19 | Southern Research Institute | Anti-angiogenic agents and methods of use |
| SI3231793T1 (sl) * | 2014-12-12 | 2020-07-31 | Japan Tobacco Inc. | Spojine dihidropirimidin-2-ona in njihove medicinske uporabe |
| CN111741947B (zh) | 2018-02-28 | 2024-06-11 | 日本烟草产业株式会社 | 4-甲基二氢嘧啶酮化合物及其药物用途 |
| CN112724070B (zh) * | 2021-01-08 | 2022-11-25 | 南京方生和医药科技有限公司 | 一种α，α-二苯基-4-哌啶甲醇的制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1252315A (pt) * | 1969-06-05 | 1971-11-03 | ||
| US3960863A (en) * | 1974-06-25 | 1976-06-01 | Sankyo Company Limited | Pyrido[1,2-a]pyrimidinone derivatives |
| DE3000923A1 (de) * | 1979-01-17 | 1980-07-31 | Degussa | Neue n-alkoxy-dithienylpiperidine |
| US4342870A (en) * | 1980-03-28 | 1982-08-03 | Janssen Pharmaceutica N.V. | Novel 3-(1-piperidinylalkyl)-4H-pyrido[1,2-a]pyrimidin-4-one derivatives |
| US4443451A (en) * | 1981-07-15 | 1984-04-17 | Janssen Pharmaceutica N.V. | Bicyclic pyrimidin-5-one derivatives |
-
1983
- 1983-07-27 US US06/517,612 patent/US4485107A/en not_active Expired - Lifetime
- 1983-09-06 IN IN1090/CAL/83A patent/IN159576B/en unknown
- 1983-09-15 CA CA000436799A patent/CA1211438A/en not_active Expired
- 1983-09-29 DE DE8383201393T patent/DE3378825D1/de not_active Expired
- 1983-09-29 EP EP83201393A patent/EP0110435B1/en not_active Expired
- 1983-10-13 PT PT77493A patent/PT77493B/pt not_active IP Right Cessation
- 1983-10-18 NZ NZ205993A patent/NZ205993A/en unknown
- 1983-10-19 CS CS837663A patent/CS238396B2/cs unknown
- 1983-10-21 PH PH29745A patent/PH20483A/en unknown
- 1983-10-27 GR GR72809A patent/GR81277B/el unknown
- 1983-10-27 SU SU833656351A patent/SU1313349A3/ru active
- 1983-10-28 ES ES526868A patent/ES8601965A1/es not_active Expired
- 1983-10-28 ZW ZW232/83A patent/ZW23283A1/xx unknown
- 1983-10-28 IE IE2540/83A patent/IE56180B1/en not_active IP Right Cessation
- 1983-10-28 MA MA20161A patent/MA19941A1/fr unknown
- 1983-10-31 RO RO112446A patent/RO86698B/ro unknown
- 1983-10-31 NO NO833956A patent/NO166133C/no unknown
- 1983-10-31 AU AU20834/83A patent/AU559176B2/en not_active Expired
- 1983-10-31 DK DK498483A patent/DK168919B1/da not_active IP Right Cessation
- 1983-10-31 FI FI833995A patent/FI77868C/fi not_active IP Right Cessation
- 1983-10-31 IL IL70094A patent/IL70094A0/xx not_active IP Right Cessation
- 1983-11-01 BG BG062872A patent/BG51158A3/xx unknown
- 1983-12-30 KR KR1019830004656A patent/KR870000825B1/ko not_active IP Right Cessation
-
1991
- 1991-06-18 SG SG467/91A patent/SG46791G/en unknown
- 1991-07-11 HK HK526/91A patent/HK52691A/xx not_active IP Right Cessation
-
1992
- 1992-04-03 CY CY1607A patent/CY1607A/xx unknown
-
1993
- 1993-06-16 BG BG097874A patent/BG60538B2/bg unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH20483A (en) | Novel((bis(aryl)methylene)-1-piperidinyl)-alkyl-pyrimidinones pharmaceutical compositions containing same and method of use thereof | |
| HK31885A (en) | 2-hydroxy-5-phenylazobenzoic acid derivatives and pharmaceutical compositions containing them | |
| IL61936A (en) | Derivatives of cba2 and pharmaceutical compositions containing them | |
| GB2071095B (en) | Heterocyclic compounds processes for their preparation and pharmaceutical compositions containing them | |
| IL70656A (en) | Pharmaceutical compositions containing phenothiazone derivatives and analogs thereof and certain such novel compounds | |
| PT77281A (en) | Process for preparing n-formyl and n-hydroxymethyl-3-phenoxy-1-azetidinecarboxamides and of pharmaceutical compositions containing the same | |
| DE3168067D1 (en) | 2-guanidino-4-heteroarylthiazoles and pharmaceutical compositions containing them | |
| PT79485A (en) | Process for preparing oxazolidines and of pharmaceutical compositions containing the same | |
| DE3165444D1 (en) | C-beta-d-xylopyranoside series compounds and pharmaceutical compositions containing them | |
| PH21599A (en) | Phenylalkylamines and pharmaceutical compositions containing them | |
| PT76657A (en) | Process for preparing 4-aryl-4-piperidinecarbinols and of pharmaceutical compositions containing the same | |
| PT80794A (en) | Process for the preparation of novel isoindolinyl-alkyl-piperazines and of pharmaceutical compositions containing the same | |
| ZA834326B (en) | Pharmaceutical compositions containing xylosides and lyxosides of puric and pyrimidic bases | |
| PT77217A (en) | Process for preparing 3-phenoxy-1-azetidine-carboxamides and of pharmaceutical compositions containing the same | |
| PH19352A (en) | Fluoromethylthiooxacephalosporins derivatives compositions containing same and method of use thereof | |
| PT81842B (en) | Process for the manufacture of polycyclic and of pharmaceutical compositions containing the same | |
| IL64054A (en) | Imidazolylpyridines and pharmaceutical compositions containing them | |
| IL58421A (en) | Production of(2'-5')oligoisoadenylate and pharmaceutical compositions containing it | |
| GB2081708B (en) | Novel derivatives of (1-benzyl-1h-indazol-3-yl) oxyacetic acid and pharmaceutical composition containing it | |
| PT76426A (en) | Process for preparing novel 2-beta-d-ribofuranosylselenazole-4-carboxamide compounds and of pharmaceutical compositions containing the same | |
| PT77282A (en) | Process for preparing substituted 1-pyridyloxy-3-indolylalkylamino-2-propanols and of pharmaceutical compositions containing the same | |
| GB2077258B (en) | Alkoxy-acyl carnitines process for their preparation and pharmaceutical compositions containing same | |
| IL62146A0 (en) | Guanylamidines and pharmaceutical compositions containing them | |
| GB2089799B (en) | Thiocarnitines process for their preparation and pharmaceutical compositions containing same | |
| GB2089346B (en) | New cephalosporins and pharmaceutical compositions containing them |